We are live on ! Find out more
MDT icon

Medtronic
MDT

Fund managers haven’t disclosed any holdings of MDT yet.

MDT Hedge Fund Activity: Q2 2026 in Review

2,123 of the 8,263 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q2 2026, worth a combined $86.7B — down 9.5% from $95.7B a quarter earlier.

Sellers outnumbered buyers: 243 funds closed out of MDT and 167 opened new positions — a net loss of 76 holders — while 913 trimmed existing stakes and 847 added.

The largest buyer was Arrowstreet Capital, adding an estimated $664M. The largest seller was Capital Research Global Investors, cutting an estimated $2.31B.

  • 2,123 institutional investors held Medtronic (MDT) as of Q2 2026, down from 2,244 in Q1 2026.
  • Funds reported $86.7B of Medtronic stock for Q2 2026, down 9.5% quarter-over-quarter.
  • 167 funds opened new Medtronic positions in Q2 2026 and 243 closed out, a net change of -76 holders.
  • The largest Medtronic buyer in Q2 2026 was Arrowstreet Capital, an estimated $664M added.
  • The largest Medtronic seller in Q2 2026 was Capital Research Global Investors, an estimated $2.31B sold.

Based on aggregated 13F filings for Q2 2026.